Fractionation of Fab glycosylated immunoglobulin G with concanavalin A chromatography unveils new structural properties of the molecule

Oncotarget

Volumn 7, Issue 21, 2016, Pages 31166-31176

  Huang, Tao ^a   Chen, Xueling ^a   Gu, Huan ^a   Zhao, Conghui ^b,c   Liu, Xingmu ^a   Yan, Meiling ^a   Deng, Xiaodong ^a   Zhang, Zaiping ^a   Gu, Jiang ^a,c  

^a SHANTOU UNIVERSITY MEDICAL COLLEGE   (China)

^b CAPITAL MEDICAL UNIVERSITY   (China)

^c PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

Author keywords

Asymmetry; ConA; Glycosylation; IgG; Symmetry

Indexed keywords

ASPARAGINE; ASPARAGINE LINKED OLIGOSACCHARIDE; CONCANAVALIN A; FC RECEPTOR; IMMUNOGLOBULIN F(AB) FRAGMENT; LECTIN; IMMUNOGLOBULIN G;

AFFINITY CHROMATOGRAPHY; ARTICLE; FRACTIONATION; GLYCOSYLATION; HUMAN; IMMUNOGLOBULIN STRUCTURE; SILVER STAINING; WESTERN BLOTTING; BLOOD; CHEMISTRY; CHROMATOGRAPHY; ISOLATION AND PURIFICATION; PROCEDURES;

CHEMICAL FRACTIONATION; CHROMATOGRAPHY; CONCANAVALIN A; GLYCOSYLATION; HUMANS; IMMUNOGLOBULIN FAB FRAGMENTS; IMMUNOGLOBULIN G;

EID: 84971500848     PISSN: None     EISSN: 19492553     Source Type: Journal    
DOI: 10.18632/oncotarget.9085     Document Type: Article

References (48)

1. Jefferis R. Glycosylation of recombinant antibody therapeutics. Biotechnol Prog. 2005; 21:11-16.
2. Krapp S, Mimura Y, Jefferis R, Huber R, Sondermann P. Structural analysis of human IgG-Fc glycoforms reveals a correlation between glycosylation and structural integrity. J Mol Biol. 2003; 325:979-989.
3. Arnold JN, Wormald MR, Sim RB, Rudd PM, Dwek RA. The impact of glycosylation on the biological function and structure of human immunoglobulins. Annu Rev Immunol. 2007; 25:21-50.
4. Holland M, Yagi H, Takahashi N, Kato K, Savage CO, Goodall DM, Jefferis R. Differential glycosylation of polyclonal IgG, IgG-Fc and IgG-Fab isolated from the sera of patients with ANCA-associated systemic vasculitis. Biochim Biophys Acta. 2006; 1760:669-677.
5. Stadlmann J, Pabst M, Altmann F. Analytical and Functional Aspects of Antibody Sialylation. J Clin Immunol. 2010; 30:S15-9.
6. Sox HC, Jr, Hood L. Attachment of carbohydrate to the variable region of myeloma immunoglobulin light chains. Proc Natl Acad Sci U S A. 1970; 66:975-982.
7. Fujimura Y, Tachibana H, Eto N, Yamada K. Antigen binding of an ovomucoid-specific antibody is affected by a carbohydrate chain located on the light chain variable region. Biosci Biotechnol Biochem. 2000; 64:2298-2305.
8. Wright A, Tao MH, Kabat EA, Morrison SL. Antibody variable region glycosylation: position effects on antigen binding and carbohydrate structure. EMBO J. 1991; 10:2717-2723.
9. Coloma MJ, Trinh RK, Martinez AR, Morrison SL. Position effects of variable region carbohydrate on the affinity and in vivo behavior of an anti-(1->6) dextran antibody. J Immunol. 1999; 162:2162-2170.
10. Youings A, Chang SC, Dwek RA, Scragg IG. Site-specific glycosylation of human immunoglobulin G is altered in four rheumatoid arthritis patients. Biochem J. 1996; 314:621-630.
11. Mimura Y, Ashton PR, Takahashi N, Harvey DJ, Jefferis R. Contrasting glycosylation profiles between Fab and Fc of a human IgG protein studied by electrospray ionization mass spectrometry. J Immunol Methods. 2007; 326:116-126.
12. Borel IM, Gentile T, Angelucci J, Margni RA, Binaghi RA. Asymmetrically glycosylated IgG isolated from nonimmune human sera. Biochim Biophys Acta. 1989; 990:162-164.
13. Kobata A, Endo T. Immobilized lectin columns: useful tools for the fractionation and structural analysis of oligosaccharides. J Chromatogr. 1992; 597:111-122.
14. Spiegelberg HL, Abel CA, Fishkin BG, Grey HM. Localization of the carbohydrate within the variable region of light and heavy chains of human gamma g myeloma proteins. Biochemistry. 1970; 9:4217-4223.
15. Chen Z, Qiu X, Gu J. Immunoglobulin expression in nonlymphoid lineage and neoplastic cells. Am J Pathol. 2009; 174:1139-1148.
16. Wright A, Morrison SL. Antibody variable region glycosylation: biochemical and clinical effects. Springer Semin Immunopathol. 1993; 15:259-273.
17. Osawa T, Tsuji T. Fractionation and structural assessment of oligosaccharides and glycopeptides by use of immobilized lectins. Annu Rev Biochem. 1987; 56:21-42.
18. Shibuya N, Goldstein IJ, Broekaert WF, Nsimba-Lubaki M, Peeters B, Peumans WJ. The elderberry (Sambucus nigra L.) bark lectin recognizes the Neu5Ac(alpha 2-6)Gal/GalNAc sequence. J Biol Chem. 1987; 262:1596-1601.
19. Wang WC, Cummings RD. The immobilized leukoagglutinin from the seeds of Maackia amurensis binds with high affinity to complex-type Asn-linked oligosaccharides containing terminal sialic acid-linked alpha-2, 3 to penultimate galactose residues. J Biol Chem. 1988; 263:4576-4585.
20. Shibuya N, Goldstein IJ, Van Damme EJ, Peumans WJ. Binding properties of a mannose-specific lectin from the snowdrop (Galanthus nivalis) bulb. J Biol Chem. 1988; 263:728-734.
21. Crowley JF, Goldstein IJ, Arnarp J, Lonngren J. Carbohydrate binding studies on the lectin from Datura stramonium seeds. Arch Biochem Biophys. 1984; 231: 524-533.
22. Goldstein IJ, Hollerman CE, Smith EE. Protein-Carbohydrate Interaction. Ii. Inhibition Studies on the Interaction of Concanavalin a with Polysaccharides. Biochemistry. 1965; 4:876-883.
23. Poljak RJ. Three-dimensional structure, function and genetic control of immunoglobulins. Nature. 1975; 256:373-376.
24. Deisenhofer J. Crystallographic refinement and atomic models of a human Fc fragment and its complex with fragment B of protein A from Staphylococcus aureus at 2.9-and 2.8-A resolution. Biochemistry. 1981; 20:2361-2370.
25. Stadlmann J, Weber A, Pabst M, Anderle H, Kunert R, Ehrlich HJ, Peter Schwarz H, Altmann F. A close look at human IgG sialylation and subclass distribution after lectin fractionation. Proteomics. 2009; 9:4143-4153.
26. Scallon BJ, Tam SH, McCarthy SG, Cai AN, Raju TS. Higher levels of sialylated Fc glycans in immunoglobulin G molecules can adversely impact functionality. Mol Immunol. 2007; 44:1524-1534.
27. Anthony RM, Nimmerjahn F, Ashline DJ, Reinhold VN, Paulson JC, Ravetch JV. Recapitulation of IVIG antiinflammatory activity with a recombinant IgG Fc. Science. 2008; 320:373-376.
28. Kaneko Y, Nimmerjahn F, Ravetch JV. Anti-inflammatory activity of immunoglobulin G resulting from Fc sialylation. Science. 2006; 313:670-673.
29. Natsume A, Wakitani M, Yamane-Ohnuki N, Shoji-Hosaka E, Niwa R, Uchida K, Satoh M, Shitara K. Fucose removal from complex-type oligosaccharide enhances the antibody-dependent cellular cytotoxicity of single-geneencoded antibody comprising a single-chain antibody linked the antibody constant region. J Immunol Methods. 2005; 306:93-103.
30. Shinkawa T, Nakamura K, Yamane N, Shoji-Hosaka E, Kanda Y, Sakurada M, Uchida K, Anazawa H, Satoh M, Yamasaki M, Hanai N, Shitara K. The absence of fucose but not the presence of galactose or bisecting N-acetylglucosamine of human IgG1 complex-type oligosaccharides shows the critical role of enhancing antibody-dependent cellular cytotoxicity. J Biol Chem. 2003; 278:3466-3473.
31. Takahashi M, Kuroki Y, Ohtsubo K, Taniguchi N. Core fucose and bisecting GlcNAc, the direct modifiers of the N-glycan core: their functions and target proteins. Carbohydr Res. 2009; 344:1387-1390.
32. Masuda K, Kubota T, Kaneko E, Iida S, Wakitani M, Kobayashi-Natsume Y, Kubota A, Shitara K, Nakamura K. Enhanced binding affinity for FcgammaRIIIa of fucose-negative antibody is sufficient to induce maximal antibody-dependent cellular cytotoxicity. Mol Immunol. 2007; 44:3122-3131.
33. Malhotra R, Wormald MR, Rudd PM, Fischer PB, Dwek RA, Sim RB. Glycosylation changes of IgG associated with rheumatoid arthritis can activate complement via the mannose-binding protein. Nat Med. 1995; 1:237-243.
34. Yuan S, Li Q, Zhang Y, Huang C, Wu H, Li Y, Liu Y, Yu N, Zhang H, Lu G, Gao Y, Gao Y, Guo X. Changes in antithyroglobulin IgG glycosylation patterns in Hashimoto's thyroiditis patients. J Clin Endocrinol Metab. 2015; 100:717-724.
35. Parekh RB, Dwek RA, Sutton BJ, Fernandes DL, Leung A, Stanworth D, Rademacher TW, Mizuochi T, Taniguchi T, Matsuta K, et al. Association of rheumatoid arthritis and primary osteoarthritis with changes in the glycosylation pattern of total serum IgG. Nature. 1985; 316:452-457.
36. Bondt A, Selman MH, Deelder AM, Hazes JM, Willemsen SP, Wuhrer M, Dolhain RJ. Association between galactosylation of immunoglobulin G and improvement of rheumatoid arthritis during pregnancy is independent of sialylation. J Proteome Res. 2013; 12:4522-4531.
37. Parekh R, Roitt I, Isenberg D, Dwek R, Rademacher T. Agerelated galactosylation of the N-linked oligosaccharides of human serum IgG. J Exp Med. 1988; 167:1731-1736.
38. Ruhaak LR, Uh HW, Beekman M, Koeleman CA, Hokke CH, Westendorp RG, Wuhrer M, Houwing-Duistermaat JJ, Slagboom PE, Deelder AM. Decreased levels of bisecting GlcNAc glycoforms of IgG are associated with human longevity. PLoS One. 2010; 5:e12566.
39. Yamada E, Tsukamoto Y, Sasaki R, Yagyu K, Takahashi N. Structural changes of immunoglobulin G oligosaccharides with age in healthy human serum. Glycoconj J. 1997; 14:401-405.
40. Kasermann F, Boerema DJ, Ruegsegger M, Hofmann A, Wymann S, Zuercher AW, Miescher S. Analysis and functional consequences of increased Fab-sialylation of intravenous immunoglobulin (IVIG) after lectin fractionation. PLoS One. 2012; 7:e37243.
41. Rademacher TW, Parekh RB, Dwek RA. Glycobiology. Annu Rev Biochem. 1988; 57:785-838.
42. Fykse EM, Sletten K, Husby G, Cornwell GG, 3rd. The primary structure of the variable region of an immunoglobin IV light-chain amyloid-fibril protein (AL GIL). The Biochem J. 1988; 256:973-980.
43. Holm E, Sletten K, Husby G. Structural studies of a carbohydrate-containing immunoglobulin-lambda-lightchain amyloid-fibril protein (AL) of variable subgroup III. Biochem J. 1986; 239:545-551.
44. Tveteraas T, Sletten K, Westermark P. The amino acid sequence of a carbohydrate-containing immunoglobulinlight-chain-type amyloid-fibril protein. Biochem J. 1985; 232:183-190.
45. Gala FA, Morrison SL. V region carbohydrate and antibody expression. J Immunol. 2004; 172:5489-5494.
46. Bondt A, Rombouts Y, Selman MH, Hensbergen PJ, Reiding KR, Hazes JM, Dolhain RJ, Wuhrer M. Immunoglobulin G (IgG) Fab glycosylation analysis using a new mass spectrometric high-throughput profiling method reveals pregnancy-associated changes. Mol Cell Proteomics. 2014; 13:3029-3039.
47. Mahan AE, Tedesco J, Dionne K, Baruah K, Cheng HD, De Jager PL, Barouch DH, Suscovich T, Ackerman M, Crispin M, Alter G. A method for high-throughput, sensitive analysis of IgG Fc and Fab glycosylation by capillary electrophoresis. J Immunol Methods. 2015; 417:34-44.
48. Brown EP, Normandin E, Osei-Owusu NY, Mahan AE, Chan YN, Lai JI, Vaccari M, Rao M, Franchini G, Alter G, Ackerman ME. Microscale purification of antigen-specific antibodies. J Immunol Methods. 2015; 425:27-36.